Category & trade
Primary
brain-and-nervous-system-disorders · embed-ft 0.56
Tree path
Medical Health › Diseases and Conditions › Brain and Nervous System Disorders
Group (tier-1)
Tech stack
AI readiness
AI-Readiness score
34 / 100 · partial · see similar
AI training policy
allowed
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
BlueRock Therapeutics – exPDite-2 Study for Parkinson's disease
Description
No Time to Waste exPDite-2 is a double-blind, simulated surgery-controlled phase 3 study evaluating the potential efficacy and safety of an investigational cell therapy called bemdaneprocel (bem-da-nepro-cell). Find out if you or someone you know is right for exPDite-2 OR Call us at +1-877-380-3967 to see if you may participate Bemdaneprocel
Final URL
Language
en (html)
Scanned at
2026-07-05 23:56:14